Tickling PARPs into serine action
暂无分享,去创建一个
[1] I. Ahel,et al. HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation , 2020, Nature.
[2] I. Matic,et al. Serine is the major residue for ADP-ribosylation upon DNA damage , 2018, eLife.
[3] Arnab Ray Chaudhuri,et al. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling , 2017, Nature Reviews Molecular Cell Biology.
[4] M. Robson,et al. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation , 2017, The New England journal of medicine.
[5] I. Matic,et al. Serine ADP-Ribosylation Depends on HPF1 , 2017, Molecular cell.
[6] Ziying Liu,et al. PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes. , 2017, Genes & development.
[7] M. L. Nielsen,et al. Proteome-wide identification of the endogenous ADP-ribosylome of mammalian cells and tissue , 2016, Nature Communications.
[8] I. Matic,et al. Serine is a new target residue for endogenous ADP-ribosylation on histones , 2016, Nature chemical biology.
[9] I. Ahel,et al. HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity , 2016, Molecular cell.
[10] Jamin D Steffen,et al. PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain. , 2015, Molecular cell.
[11] M. O’Connor,et al. Targeting the DNA Damage Response in Cancer. , 2015, Molecular cell.
[12] I. Ahel,et al. Structures and Mechanisms of Enzymes Employed in the Synthesis and Degradation of PARP-Dependent Protein ADP-Ribosylation. , 2015, Molecular cell.
[13] Anthony K. L. Leung,et al. Phosphoproteomic Approach to Characterize Protein Mono- and Poly(ADP-ribosyl)ation Sites from Cells , 2014, Journal of proteome research.
[14] David R Goodlett,et al. Mapping PARP-1 auto-ADP-ribosylation sites by liquid chromatography-tandem mass spectrometry. , 2013, Journal of proteome research.
[15] V. Schreiber,et al. The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. , 2012, Biochemical pharmacology.
[16] W. Kraus,et al. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs , 2012, Nature Reviews Molecular Cell Biology.
[17] J. Pascal,et al. Structural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1 , 2012, Science.
[18] D. Matei,et al. Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. , 2012, The New England journal of medicine.
[19] A. Caflisch,et al. PARP1 ADP-ribosylates lysine residues of the core histone tails , 2010, Nucleic acids research.
[20] Bernhard Lüscher,et al. Toward a unified nomenclature for mammalian ADP-ribosyltransferases. , 2010, Trends in biochemical sciences.
[21] P. Chambon,et al. Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. , 1963, Biochemical and biophysical research communications.